ABT-107 is a selective α7 neuronal nicotinic receptor agonist. ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions.
사양
동의어
ABT-107 free base | ABT-107 | (3R)-3-((6-(1H-Indol-5-yl)-3-pyridazinyl)oxy)-1-azabicyclo(2.2.2)octane | 5-{6-[(3R)-1-azabicyclo[2.2.2]oct-3-yloxy]pyridazin-3-yl}-1H-indole | 1-AZABICYCLO(2.2.2)OCTANE, 3-((6-(1H-INDOL-5-YL)-3-PYRIDAZINYL)OXY)-, (3R)- | ABT 107 | 5-{6-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]pyridazin-3-yl}-1H-indole | ABT-PR Show more
사양 및 순도
≥98%
생화학 및 생리적 메커니즘
ABT-107 is a selective α7 neuronal nicotinic receptor agonist. ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions.
보관 조건
Store at -20°C
배송
Ice chest + Ice pads
이 제품은 콜드 체인 배송이 필요합니다.지상 및 기타 경제 서비스는 사용할 수 없습니다.
작업 유형
AGONIST
작동 메커니즘
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
This compound belongs to the class of organic compounds known as indoles. These are compounds containing an indole moiety, which consists of pyrrole ring fused to benzene to form 2,3-benzopyrrole.
External Descriptors
Not available
1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.